Detalles de la búsqueda
1.
Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme.
Europace
; 22(1): 47-57, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31651951
2.
Incorporating patient generated health data into pharmacoepidemiological research.
Pharmacoepidemiol Drug Saf
; 29(12): 1540-1549, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33146896
3.
Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
Respiration
; 99(2): 108-118, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31982886
4.
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program.
Am Heart J
; 218: 123-127, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31806087
5.
Cardiovascular safety of linagliptin compared with other oral glucose-lowering agents in patients with type 2 diabetes: A sequential monitoring programme in routine care.
Diabetes Obes Metab
; 21(8): 1824-1836, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30941884
6.
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry.
Am Heart J
; 198: 55-63, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29653649
7.
Safety of non-insulin glucose-lowering drugs in pregnant women with pre-gestational diabetes: A cohort study.
Diabetes Obes Metab
; 20(7): 1642-1651, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29498473
8.
Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records.
Diabetes Obes Metab
; 20(4): 974-984, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29206336
9.
Real world management of pregestational diabetes not achieving glycemic control for many patients in the UK.
Pharmacoepidemiol Drug Saf
; 27(8): 940-948, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29740916
10.
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Europace
; 18(9): 1308-18, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27335063
11.
Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations.
Diabetologia
; 57(11): 2237-50, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25212258
12.
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation.
Am Heart J
; 167(3): 329-34, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24576516
13.
Prospective cohort studies of newly marketed medications: using covariate data to inform the design of large-scale studies.
Epidemiology
; 25(1): 126-33, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24240651
14.
Metrics for covariate balance in cohort studies of causal effects.
Stat Med
; 33(10): 1685-99, 2014 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24323618
15.
Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcome.
Haematologica
; 97(3): 402-9, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22058224
16.
Procalcitonin and valuable clinical symptoms in the early detection of neonatal late-onset bacterial infection.
Acta Paediatr
; 101(1): 19-25, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21824193
17.
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry.
Clin Res Cardiol
; 111(5): 548-559, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35294623
18.
Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.
PLoS One
; 17(10): e0274237, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36201473
19.
Choosing Among Common Data Models for Real-World Data Analyses Fit for Making Decisions About the Effectiveness of Medical Products.
Clin Pharmacol Ther
; 107(4): 827-833, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31330042
20.
Safety and Effectiveness of Dabigatran and Other Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation.
Clin Pharmacol Ther
; 107(6): 1405-1419, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31869437